Abstract Submission Information
Abstract Acceptance Announced: August 1, 2026
Late Breaking Abstract Submission Opens: September 1, 2026
Late Breaking Abstract Submission Deadline: September 14, 2026 (11:59 pm ET)
Late Breaking Abstract Acceptance Announced: October 1, 2026
This meeting focuses on ataxias while embracing lessons from broader research that inform shared biological pathways or therapeutic development. Abstracts highlighting pathways, technologies, or strategies with potential relevance to ataxias will be considered.
ICAR is introducing a new registration and abstract submission platform this year. Regardless of whether you’ve participated in ICAR before, you will need to create a new login (profile) in the new system.
Late-Breaking Abstract Submission:
The International Congress for Ataxia Research (ICAR) is currently accepting submissions for Late-Breaking Abstracts from September 1 until September 14.
Instructions:
-
Late-breaking abstract must cover research that is of sufficient scientific importance to merit expedited presentation and should contain new information that was not yet known or fully available by the abstract submission deadline — June 1, 2026.
-
Late-breaking abstract must not be a revision of an abstract submitted prior to the original submission deadline and must not have been presented, accepted for presentation, or published at any other scientific meeting or journal at the time of submission.
-
The late-breaking abstract deadline is not an extension of the abstract submission deadline. Only a very limited number of late-breaking abstracts will be selected.
Submitting an Abstract
To submit an abstract, click the button below (will be visible when abstracts are open). You will be prompted to create a login for the conference abstract submission software X-CD. Abstracts can be submitted under the following topics:
- Advances in genetics and diagnostics (including abstracts on new genes causing ataxia)
- Disease mechanisms (dominant ataxias)
- Disease mechanisms (recessive and non-hereditary ataxias)
- Emerging and existing therapeutics - pre-clinical research
- Emerging and existing therapeutics - clinical research
- Biomarkers (including imaging, fluid etc.)
- Clinical studies (including abstracts on patient preferences, natural history and observational studies, clinical outcomes and other clinical research), cognitive disorders and other non-motor features.
Abstract Format:
Abstract title should be a maximum of 150 characters (including spaces).
All authors must be listed, and one author noted as the presenting author.
Each author’s title and institution should be noted.
Abstract text must be limited to 300 words and should include the following paragraphs: Background and objectives, Methods, Results, Discussion and Conclusion.
Travel bursaries are available for junior investigators including students, postdocs of 5 or fewer years (accounting for career disruptions), medical residents or fellows and working in a mentored environment. To apply for a travel bursary, submit:
- your CV (one page, include your research interest and list up to 5 most relevant publications)
- very brief statement (200-word limit) outlining your motivation for attending the conference and emphasizing alignment with your research and professional development
To be eligible for a bursary, your abstract must be selected for a poster or oral presentation, and you must be the presenting author.